首页> 外文期刊>Nucleic Acids Research >Inhibition of DNA replication fork progression and mutagenic potential of 1,N-6-ethenoadenine and 8-oxoguanine in human cell extracts
【24h】

Inhibition of DNA replication fork progression and mutagenic potential of 1,N-6-ethenoadenine and 8-oxoguanine in human cell extracts

机译:抑制人类细胞提取物中1,N-6-乙炔腺嘌呤和8-氧代鸟嘌呤的DNA复制叉进程和诱变潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Comparative mutagenesis of 1,N-6-ethenoadenine (A) and 8-oxoguanine (8-oxoG), two endogenous DNA lesions that are also formed by exogenous DNA damaging agents, have been evaluated in HeLa and xeroderma pigmentosum variant (XPV) cell extracts. Two-dimensional gel electrophoresis of the duplex M13mp2SV vector containing these lesions established that there was significant inhibition of replication fork movement past A, whereas 8-oxoG caused only minor stalling of fork progression. In extracts of HeLa cells, A was weakly mutagenic inducing all three base substitutions in approximately equal frequency, whereas 8-oxoG was 10-fold more mutagenic inducing primarily GT transversions. These data suggest that 8-oxoG is a miscoding lesion that presents a minimal, if any, block to DNA replication in human cells. We hypothesized that bypass of A proceeded principally by an error-free mechanism in which the undamaged strand was used as a template, since this lesion strongly blocked fork progression. To examine this, we determined the sequence of replication products derived from templates in which a G was placed across from the A. Consistent with our hypothesis, 93 of the progeny were derived from replication of the undamaged strand. When translesion synthesis occurred, AT mutations increased 3-fold in products derived from the mismatched A: G construct compared with those derived from the A: T construct. More efficient repair of A in the A: T construct may have been responsible for lower mutation frequency. Primer extension studies with purified pol have shown that this polymerase is highly error-prone when bypassing A. To examine if pol is the primary mutagenic translesion polymerase in human cells, we determined the lesion bypass characteristics of extracts derived from XPV cells, which lack this polymerase. The A: T construct induced AG and AC mutant frequencies that were approximately the same as those observed using the HeLa extracts. However, AT events were increased 5-fold relative to HeLa extracts. These data support a model in which pol -mediated translesion synthesis past this adduct is error-free in the context of semiconservative replication in the presence of fidelity factors such as PCNA.
机译:已在HeLa和色皮病变种(XPV)细胞中评估了1,N-6-乙炔腺嘌呤(A)和8-氧代鸟嘌呤(8-oxoG)的比较诱变,这两种内源性DNA损伤也是由外源DNA破坏剂形成的。提取物。包含这些损伤的双链体M13mp2SV载体的二维凝胶电泳确定,复制叉的移动明显超过A,而8-oxoG仅引起叉的缓慢停滞。在HeLa细胞提取物中,A几乎以相同的频率弱诱变所有三个碱基,而8-oxoG诱变主要诱导GT转化的诱变多10倍。这些数据表明8-oxoG是一种编码错误的损伤,对人类细胞中的DNA复制产生的阻碍很小(如果有的话)。我们假设绕过A主要是通过一种无错误的机制进行的,其中使用未损坏的链作为模板,因为这种病变强烈地阻止了叉子的前进。为了检查这一点,我们确定了从模板中复制出的产物序列,在模板中将G置于A的对面。与我们的假设一致,后代中的93个来源于未受损链的复制。当发生跨病变合成时,与由A:T构建体衍生的产物相比,由错配的A:G构建体衍生的产物中的AT突变增加了3倍。 A:T构建体中A的更有效修复可能是造成较低突变频率的原因。使用纯化的pol进行引物延伸研究表明,绕过A时,该聚合酶极易出错。要检查pol是否是人细胞中的主要诱变性跨病变聚合酶,我们确定了XPV细胞提取物的病变绕过特性,而该特性缺乏这种特性。聚合酶。 A:T构建体诱导的AG和AC突变频率与使用HeLa提取物观察到的频率大致相同。但是,AT事件相对于HeLa提取物增加了5倍。这些数据支持这样的模型,其中在存在保真因子(例如PCNA)的情况下,在半保守复制的情况下,经过该加合物的pol介导的病变合成是无错误的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号